Investment Q&A

Q: From the media: “ Amgen stock slouched Wednesday after a Lilly exec called the company's early-stage test results for a weight-loss drug "a bit underwhelming."

Huh? What did they expect a competitor to say? I thought the quarterly results were good and the new drug seems quite promising.

What is 5i's take on the AMGN recent quarter (which beat) and future prospects? Wouldn’t it be better to buy AMGN after the sell-off than pay the overhyped price commanded by LLY?

Q: Hi team,

Grateful if you could update your views on Altimmune (ALT-Q).

Is it a buy now for aggressive growth ? Which other companies would would you consider more suitable now in healthcare for strong grow on short term and which risk would be associated ?

Gratefully,

Jacques IDS

Q: Was considering adding to a small $lnth position to bump it up. Also have lly, abbv, well. Would you please provide an update opinion - potential in 2024/25 or value trap? Technically it is just perking up a bit.

Q: Hi, Could you give us your opinion on Vertex, specially after release of its earnings, yesterday. How is the growth trajectory and pipeline ? Does the recent pull back, notably after the earnings, today, presents a good opportunity to initiate a new position ? Thank You

Q: Any news for the big price surge today ( Tuesday) ? Thanks a million.

Q: Looking for your latest view on this stock looking at replacing it with WELL but GUD did very good on its last earning report but market doesn't appear to be to impressed,wondering if you would hold until their next earning report or just move on.

Q: Could you please comment on last week's NR from DHT.UN (see below). The market responded favourably and so did the analysts with a multitude of raised targets. Thanks as always.

Immediate and accretive cash flow generation replaces structured annual caps –

– Increasing capital deployment guidance to over US$1.25 billion deployed for the five years ending 2025 –

– Now expecting high-teens Royalty Income CAGR through 2025 and mid- to high-single digit Royalty Income CAGR through 2030, excluding any new transactions –

this is the press release we are referencing.

https://drihealthcare.com/dri-healthcare-trust-announces-the-expansion-of-its-royalty-entitlement-on-the-us-net-sales-of-omidria-updates-deployment-and-cagr-guidance/

Q: Your thoughts on DRI Healthcare Trust please. I am reading outperform ratings in the Globe and Mail. It is a comfort to have 5i to ask questions - thank you. Barbara

Q: Can you explain what the Well Health news this morning means for the company.

Q: RMD seems to the “king” of the sleep apnea/sleep disorder space. Are there others such as, NYXH:US, perhaps, that you find interesting currently?

Q: Why is Well Health under so much bearish pressure?

Q: Looks like an interesting turnaround play.

Q: Why can't the stock price get any traction. It just had three very good releases and it continues to drift down. Seems like it is in the penalty box for no reason.

Q: These stocks are my US non registered portfolio, and are all at a loss, to varying degrees. Which stocks would you hold, which ones to sell, and what would you replace them with? Any sector, moderate risk

Q: Can I please have your thoughts re this company. It is about 6-7 months that the stock has been pretty flat - not moving much in either direction. I believe that at one time there may have been (and possibly still is) an offer on the table? I am wondering if it is time to move on... Thanks.

Q: May I have your opinion of MD.TO? With appreciation,
Ed

Q: I know you guys are not warm and fuzzy about these guys and don't follow them anymore, but for some reason I find them, let's say, "interesting". Their CIRO trading halt order is a week and a half old now with no news. This is obviously due to their late filings. It's either going to be really good or really bad. Do you have a wild guess and opinion?

Q: I hold Gardant in a riff. I am down 70% on the name. I am thinking of selling to look for better opportunities. Could I have your opinion please. Thank you.

Q: 1. has well ever been in a profit since inception if so what year and what was the EPS. that year. .2. what is the EPS projection for WELL for 2024 year . 3. what is the projection for EPS for 2025 year. 4. what is the share count for years ended 2022 and 2023. 5. have the insiders been buying more shares at depressed market prices or just exercising options at lower prices and selling.into the market thanks Richard

Q: Hi 5i Team,

May I please have your thoughts on UNH? Is it a hold, sell or buy? Would you also recommend an alternative to it.
Cheers,
Harry